β2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.BackgroundA local inflammatory reaction to β2-microglobulin (β2m) amyloid deposits by monocytes/macrophages is a characteristic histologic feature of dialysis-related amyloidosis (DRA). Since β2m modified with advanced glycation end products (AGE-β2m) is a major constituent of amyloid in DRA, we tested the hypothesis that AGE-β2m affects apoptosis and phenotype of human monocytes.MethodsHuman peripheral blood monocytes were incubated with or without in vitro-derived AGE-β2m, and their viability, extent of apoptosis, morphology, and function examined over the subsequent four days.ResultsAGE-modified but not unmodified β2m significantly delayed spontaneou...
AbstractAntibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an attr...
AbstractDialysis-related amyloidosis is a serious complication for patients undergoing long-term hem...
Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis...
Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. We r...
Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. We r...
This is the published version. Copyright 1996 American Society for Clinical Investigation.An importa...
This is the published version. Copyright 1996 American Society for Clinical Investigation.An importa...
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. β2...
AbstractDialysis-related amyloidosis is a serious complication for patients undergoing long-term hem...
Advanced glycation endproducts (AGEs) accumulate on long-lived protein deposits, e.g. those composed...
Advanced glycation endproducts (AGEs) accumulate on long-lived protein deposits, e.g. those composed...
The formation of insoluble amyloid fibrils is associated with an array of devastating human diseases...
BACKGROUND: beta2-microglobulin (beta2m) is considered to be the amyloidogenic precursor in dialysis...
Objective. Increased monocytes, particularly the inflammatory subset, are associated with accelerate...
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. β2...
AbstractAntibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an attr...
AbstractDialysis-related amyloidosis is a serious complication for patients undergoing long-term hem...
Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis...
Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. We r...
Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. We r...
This is the published version. Copyright 1996 American Society for Clinical Investigation.An importa...
This is the published version. Copyright 1996 American Society for Clinical Investigation.An importa...
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. β2...
AbstractDialysis-related amyloidosis is a serious complication for patients undergoing long-term hem...
Advanced glycation endproducts (AGEs) accumulate on long-lived protein deposits, e.g. those composed...
Advanced glycation endproducts (AGEs) accumulate on long-lived protein deposits, e.g. those composed...
The formation of insoluble amyloid fibrils is associated with an array of devastating human diseases...
BACKGROUND: beta2-microglobulin (beta2m) is considered to be the amyloidogenic precursor in dialysis...
Objective. Increased monocytes, particularly the inflammatory subset, are associated with accelerate...
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. β2...
AbstractAntibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an attr...
AbstractDialysis-related amyloidosis is a serious complication for patients undergoing long-term hem...
Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis...